TIDES Asia: Peptide Track
Discover how peptide innovators are overcoming delivery, manufacturability, and scale-up barriers to advance more complex therapeutics.
The Peptide Track showcases the latest advances across peptide discovery, delivery, translational development, and manufacturing. Covering oral peptides, peptide shuttles, macrocycles, venom-derived candidates, antifungal peptides, targeting agents, and next-generation production technologies, this track is built for teams looking to connect peptide innovation with real-world development and commercial execution.
About the Peptide Track
The Peptide Track brings together the science and manufacturing strategies reshaping peptide therapeutics. Attendees will hear how innovators are addressing long-standing challenges in stability, delivery, selectivity, synthesis, purification, and sustainability, while advancing increasingly sophisticated peptide modalities toward the clinic.
Oral peptide therapeutics
Learn how developers are designing gut-stable peptides and opening new opportunities for gastrointestinal indications. Discover how developers are improving gene silencing, splice correction, and therapeutic durability while reducing off-target effects.
BBB delivery and peptide shuttles
Explore how shuttle technologies are being developed to transport therapeutics across the blood-brain barrier and into hard-to-reach disease settings.
Macrocycles and constrained peptides
See how highly constrained and cyclic peptide formats are expanding the druggable landscape for difficult targets. Learn how backbone, seed-region, and other molecular modifications are being used to enhance efficacy, safety, and tolerability.
Venom-derived and engineered peptide candidates
Discover how naturally occurring peptide scaffolds are being optimized into selective therapeutic leads.
Peptide targeting agents and discovery platforms
Examine high-throughput discovery and targeting approaches that are accelerating preclinical peptide development.
Manufacturing, purification, and sustainability
Gain insight into LPPS, expanded genetic code biomanufacturing, and integrated approaches that move beyond conventional SPPS.
Industry challenges we’ll address at TIDES Asia
How to improve peptide stability and make oral delivery more viable.
How to overcome blood-brain barrier limitations for peptide-based therapeutics.
How to advance macrocycles, constrained peptides, and other complex formats toward clinical development.
How to identify selective hits faster through high-throughput discovery and screening approaches.
How to improve synthesis, purification, and process robustness for increasingly sophisticated peptides.
How to build more scalable and sustainable manufacturing strategies beyond traditional SPPS.
Who will benefit from the oligonucleotide track?
- VP / Head / Director of Peptide Discovery
- VP / Head / Director of Peptide Chemistry
- Director of Preclinical Development
- Head of Translational Science
- Director of Process Chemistry
- Director of API Development
- Director of Manufacturing
- Director of Purification / Downstream Processing
- Head of CMC
- Bioprocess Development Lead
- Formulation and Delivery Scientist
- Technical Operations Lead